Vitamin D and depression: Cellular and regulatory mechanisms

Pharmacological Reviews

Volumn 69, Issue 2, 2017, Pages 80-92

  Berridge, Michael J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INOSITOL TRISPHOSPHATE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VITAMIN D;

ALZHEIMER DISEASE; BRAIN NERVE CELL; CALCIUM SIGNALING; DEPRESSION; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; REVIEW; ANIMAL; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; CALCIUM SIGNALING; DEPRESSION; HUMANS; INFLAMMATION; NEURONS; VITAMIN D;

EID: 85013177495     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.116.013227     Document Type: Review

References (213)

1. Alexianu ME, Robbins E, Carswell S, and Appel SH (1998) 1Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells. J Neurosci Res 51:58–66.
2. Andreazza AC, Shao L, Wang JF, and Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67:360–368.
3. Andreazza AC, Wang JF, Salmasi F, Shao L, and Young LT (2013) Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 127:552–561.
4. Anglin RE, Garside SL, Tarnopolsky MA, Mazurek MF, and Rosebush PI (2012) The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. J Clin Psychiatry 73:506–512.
5. Anglin RE, Samaan Z, Walter SD, and McDonald SD (2013) Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 202: 100–107.
6. Annweiler C (2016) Vitamin D in dementia prevention. Ann N Y Acad Sci 1367: 57–63.
7. Bánsághi S, Golenár T, Madesh M, Csordás G, RamachandraRao S, Sharma K, Yule DI, Joseph SK, and Hajnóczky G (2014) Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species. J Biol Chem 289:8170–8181.
8. Bansal Y and Kuhad A (2016) Mitochondrial dysfunction in depression. Curr Neuropharmacol 14:610–618.
9. Barbosa IG, Bauer ME, Machado-Vieira R, and Teixeira AL (2014a) Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast 2014:360481.
10. Barbosa IG, Machado-Vieira R, Soares JC, and Teixeira AL (2014b) The immunology of bipolar disorder. Neuroimmunomodulation 21:117–122.
11. Beilfuss J, Berg V, Sneve M, Jorde R, and Kamycheva E (2012) Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 60:870–874.
12. Berk M, Malhi GS, Gray LJ, and Dean OM (2013a) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34:167–177.
13. Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, et al. (2013b) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200.
14. Berridge MJ (2012) Dysregulation of neural calcium signalling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 6:1–12.
15. Berridge MJ (2014a) Calcium regulation of neural rhythms, memory and Alzheimer’s disease. J Physiol 592:281–293.
16. Berridge MJ (2014b) Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res 357:477–492.
17. Berridge MJ (2015a) Vitamin D: a custodian of cell signalling stability in health and disease. Biochem Soc Trans 43:349–358.
18. Berridge MJ (2015b) Vitamin D cell signalling in health and disease. Biochem Biophys Res Commun 460:53–71.
19. Berridge MJ (2016a) Vitamin D, reactive oxygen species and calcium signalling in ageing and disease. Philos Trans R Soc Lond B Biol Sci 371:20150434.
20. Berridge MJ (2016b) The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol Rev 96:1261–1296.
21. Berridge MJ, Downes CP, and Hanley MR (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411–419.
22. Bertaso F, Roussignol G, Worley P, Bockaert J, Fagni L, and Ango F (2010) Homer1adependent crosstalk between NMDA and metabotropic glutamate receptors in mouse neurons. PLoS One 5:e9755.
23. Bird GS, Burgess GM, and Putney JW Jr. (1993) Sulfhydryl reagents and cAMPdependent kinase increase the sensitivity of the inositol 1,4,5-trisphosphate receptor in hepatocytes. J Biol Chem 268:17917–17923.
24. Björkhem-Bergman L and Bergman P (2016) Vitamin D and patients with palliative cancer. BMJ Support Palliat Care 6:287–291.
25. Black LJ, Jacoby P, Allen KL, Trapp GS, Hart PH, Byrne SM, Mori TA, Beilin LJ, and Oddy WH (2014) Low vitamin D levels are associated with symptoms of depression in young adult males. Aust N Z J Psychiatry 48:464–471.
26. Boal AH, Smith DJ, McCallum L, Muir S, Touyz RM, Dominiczak AF, and Padmanabhan S (2016) Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension 68:1132–1138.
27. 2+ spikes in HeLa cells by sensitizing the inositol 1,4,5-trisphosphate receptor. J Biol Chem 267:25113–25119.
28. Bouillon R and Verstuyf A (2013) Vitamin D, mitochondria, and muscle. J Clin Endocrinol Metab 98:961–963.
29. Bower B, Bylsma LM, Morris BH, and Rottenberg J (2010) Poor reported sleep quality predicts low positive affect in daily life among healthy and mood-disordered persons. J Sleep Res 19:323–332.
30. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, and Porter NM (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21:98–108.
31. Brites D and Fernandes A (2015) Neuroinflammation and depression: Microglia activation, extracellular microvesicles and microRNA Dysregulation. Front Cell Neurosci 9:476.
32. Brouwer-Brolsma EM, Dhonukshe-Rutten RA, van Wijngaarden JP, van der Zwaluw NL, Sohl E, In’t Veld PH, van Dijk SC, Swart KM, Enneman AW, Ham AC, et al. (2016) Low vitamin D status is associated with more depressive symptoms in Dutch older adults. Eur J Nutr 55:1525–1534.
33. Brown NC, Andreazza AC, and Young LT (2014) An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res 218:61–68.
34. Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM, Lee HK, Huganir RL, and Thompson SM (2013) Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression. Nat Neurosci 16: 464–472.
35. Calabrese F, Riva MA, and Molteni R (2016) Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target. Expert Opin Ther Targets 20:1195–1207.
36. Callaly E, Walder K, Morris G, Maes M, Debnath M, and Berk M (2015) Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini Rev Med Chem 15:355–365.
37. Calton EK, Keane KN, and Soares MJ (2015) The potential regulatory role of vitamin D in the bioenergetics of inflammation. Curr Opin Clin Nutr Metab Care 18: 367–373.
38. Catena-Dell’Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, and Marazziti D (2011) Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem 18:245–255.
39. Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, and Pilc A (2013) mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants. Neuropharmacology 66:40–52.
40. Chan R, Chan D, Woo J, Ohlsson C, Mellström D, Kwok T, and Leung P (2011) Association between serum 25-hydroxyvitamin D and psychological health in older Chinese men in a cohort study. J Affect Disord 130:251–259.
41. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, and Manji HK (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72:879–882.
42. Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, Lane TA, Tunbridge EM, Geddes JR, and Harrison PJ (2016) A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Mol Psychiatry 21:1324–1332.
43. Clay HB, Sillivan S, and Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29:311–324.
44. Consiglio M, Viano M, Casarin S, Castagnoli C, Pescarmona G, and Silvagno F (2015) Mitochondrial and lipogenic effects of vitamin D on differentiating and proliferating human keratinocytes. Exp Dermatol 24:748–753.
45. Corson TW, Woo KK, Li PP, and Warsh JJ (2004) Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. Eur Neuropsychopharmacol 14:143–150.
46. Croarkin PE, Levinson AJ, and Daskalakis ZJ (2011) Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev 35:818–825.
47. Cui J, Shao L, Young LT, and Wang JF (2007) Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144: 1447–1453.
48. Cui X, Gooch H, Groves NJ, Sah P, Burne TH, Eyles DW, and McGrath JJ (2015) Vitamin D and the brain: key questions for future research. J Steroid Biochem Mol Biol 148:305–309.
49. Dantzer R, O’Connor JC, Freund GG, Johnson RW, and Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56.
50. Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, and Khoury SJ (2015) Serum 25-hydroxyvitamin D predicts cognitive performance in adults. Neuropsychiatr Dis Treat 11:2217–2223.
51. Dean B, Gibbons AS, Tawadros N, Brooks L, Everall IP, and Scarr E (2013) Different changes in cortical tumor necrosis factor-a-related pathways in schizophrenia and mood disorders. Mol Psychiatry 18:767–773.
52. Dean O, Giorlando F, and Berk M (2011) N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36:78–86.
53. Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, and Berk M (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 16: 2965–2976.
54. Deranieh RM and Greenberg ML (2009) Cellular consequences of inositol depletion. Biochem Soc Trans 37:1099–1103.
55. Deutschenbaur L, Beck J, Kiyhankhadiv A, Mühlhauser M, Borgwardt S, Walter M, Hasler G, Sollberger D, and Lang UE (2016) Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog Neuropsychopharmacol Biol Psychiatry 64:325–333.
56. de Viragh PA, Haglid KGMR, and Celio MR (1989) Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA 86:3887–3890.
57. 2+) signaling and disease. Cell Calcium 50: 234–241.
58. Dogra S, Sona C, Kumar A, and Yadav PN (2016) Epigenetic regulation of G protein coupled receptor signaling and its implications in psychiatric disorders. Int J Biochem Cell Biol 77 (Pt B):226–239.
59. Dong HS, Han C, Jeon SW, Yoon S, Jeong HG, Huh YJ, Pae CU, Patkar AA, and Steffens DC (2016) Characteristics of neurocognitive functions in mild cognitive impairment with depression. Int Psychogeriatr 28:1181–1190.
60. Donoso P, Sanchez G, Bull R, and Hidalgo C (2011) Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front Biosci (Landmark Ed) 16:553–567.
61. Drevets WC, Zarate CA Jr., and Furey ML (2013) Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry 73:1156–1163.
62. Dubovsky SL (1993) Calcium antagonists in manic-depressive illness. Neuropsychobiology 27:184–192.
63. Dubovsky SL, Murphy J, Thomas M, and Rademacher J (1992) Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 149:118–120.
64. Duman RS and Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68–72.
65. Duman CH and Duman RS (2015) Spine synapse remodeling in the pathophysiology and treatment of depression. Neurosci Lett 601:20–29.
66. Eickholt BJ, Towers GJ, Ryves WJ, Eikel D, Adley K, Ylinen LM, Chadborn NH, Harwood AJ, Nau H, and Williams RS (2005) Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol Pharmacol 67:1426–1433.
67. Feng W, Tu J, Yang T, Vernon PS, Allen PD, Worley PF, and Pessah IN (2002) Homer regulates gain of ryanodine receptor type 1 channel complex. J Biol Chem 277: 44722–44730.
68. Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al.; Wellcome Trust Case Control Consortium (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40:1056–1058.
69. Fitzgerald PB, Laird AR, Maller J, and Daskalakis ZJ (2008) A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 29:683–695.
70. Franzen PL and Buysse DJ (2008) Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 10:473–481.
71. Friedman AK, Juarez B, Ku SM, Zhang H, Calizo RC, Walsh JJ, Chaudhury D, Zhang S, Hawkins A, Dietz DM, et al. (2016) KCNQ channel openers reverse depressive symptoms via an active resilience mechanism. Nat Commun 7:11671.
72. Frye MA, Watzl J, Banakar S, O’Neill J, Mintz J, Davanzo P, Fischer J, Chirichigno JW, Ventura J, Elman S, et al. (2007) Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32:2490–2499.
73. Furey ML and Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121–1129.
74. Galeotti N, Bartolini A, and Ghelardini C (2006) Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology 50:309–316.
75. Galeotti N, Vivoli E, Bartolini A, and Ghelardini C (2008a) A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. J Neurochem 106:2385–2394.
76. Galeotti N, Vivoli E, Norcini M, Bartolini A, and Ghelardini C (2008b) An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP protein knockdown. Neuropharmacology 55:1156–1164.
77. Gawryluk JW, Wang JF, Andreazza AC, Shao L, and Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14:123–130.
78. Gezen-Ak D, Dursun E, and Yilmazer S (2011) The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS One 6:e17553.
79. Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, and Yatham LN (2012) Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord 14:478–487.
80. Gracious BL, Finucane TL, Friedman-Campbell M, Messing S, and Parkhurst MN (2012) Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study. BMC Psychiatry 12:38.
81. Green KN and LaFerla FM (2008) Linking calcium to Abeta and Alzheimer’s disease. Neuron 59:190–194.
82. Grossmann RE, Zughaier SM, Liu S, Lyles RH, and Tangpricha V (2012) Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr 66:1072–1074.
83. Grudet C, Malm J, Westrin A, and Brundin L (2014) Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. Psychoneuroendocrinology 50:210–219.
84. Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, et al. (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60:1007–1016.
85. Harrison PJ (2016) Molecular neurobiological clues to the pathogenesis of bipolar disorder. Curr Opin Neurobiol 36:1–6.
86. Harwood AJ (2005) Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry 10:117–126.
87. Hashimoto K, Sawa A, and Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310–1316.
88. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, and Drevets WC (2007) Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64:193–200.
89. Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39:365–379.
90. Heyes S, Pratt WS, Rees E, Dahimene S, Ferron L, Owen MJ, and Dolphin AC (2015) Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol 134:36–54.
91. Hidalgo C and Donoso P (2008) Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxid Redox Signal 10: 1275–1312.
92. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr., Anderson RR, Blank IH, Parrish JA, and Elias P (1980) Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210:203–205.
93. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, and Penninx BW (2008) Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 65:508–512.
94. Hwang SY, Wei J, Westhoff JH, Duncan RS, Ozawa F, Volpe P, Inokuchi K, and Koulen P (2003) Differential functional interaction of two Vesl/Homer protein isoforms with ryanodine receptor type 1: a novel mechanism for control of intracellular calcium signaling. Cell Calcium 34:177–184.
95. Itkin A, Dupres V, Dufrêne YF, Bechinger B, Ruysschaert JM, and Raussens V (2011) Calcium ions promote formation of amyloid b-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer’s disease. PLoS One 6:e18250.
96. Jääskeläinen T, Knekt P, Suvisaari J, Männistö S, Partonen T, Sääksjärvi K, Kaartinen NE, Kanerva N, and Lindfors O (2015) Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression. Br J Nutr 113:1418–1426.
97. Jacobs BL, van Praag H, and Gage FH (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5:262–269.
98. Jacobsen JPR, Medvedev IO, and Caron MG (2012) The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse. Philos Trans R Soc Lond B Biol Sci 367: 2444–2459.
99. Johansson P, Alehagen U, van der Wal MH, Svensson E, and Jaarsma T (2016) Vitamin D levels and depressive symptoms in patients with chronic heart failure. Int J Cardiol 207:185–189.
100. Jou SH, Chiu NY, and Liu CS (2009) Mitochondrial dysfunction and psychiatric disorders. Chang Gung Med J 32:370–379.
101. 2+) channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes. J Physiol 594:5823–5837.
102. Kalueff AV, Eremin KO, and Tuohimaa P (2004) Mechanisms of neuroprotective action of vitamin D(3). Biochemistry (Mosc) 69:738–741.
103. Kato T (2007) Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21:1–11.
104. Kaup AR, Byers AL, Falvey C, Simonsick EM, Satterfield S, Ayonayon HN, Smagula SF, Rubin SM, and Yaffe K (2016) Trajectories of depressive symptoms in older adults and risk of dementia. JAMA Psychiatry 73:525–531.
105. Kempermann G, Song H, and Gage FH (2015) Neurogenesis in the adult hippocampus. Cold Spring Harb Perspect Biol 7:a018812.
106. Kerr DC, Zava DT, Piper WT, Saturn SR, Frei B, and Gombart AF (2015) Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res 227:46–51.
107. Kida J, Nemoto K, Ikejima C, Bun S, Kakuma T, Mizukami K, and Asada T (2016) Impact of depressive symptoms on conversion from mild cognitive impairment subtypes to Alzheimer’s Disease: A community-based longitudinal study. J Alzheimers Dis 51:405–415.
108. Kim HK, Andreazza AC, Yeung PY, Isaacs-Trepanier C, and Young LT (2014) Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. J Psychiatry Neurosci 39:276–285.
109. Kim HJ and Thayer SA (2009) Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol 75:1021–1030.
110. Klausberger T, Magill PJ, Márton LF, Roberts JD, Cobden PM, Buzsáki G, and Somogyi P (2003) Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature 421:844–848.
111. Kobayashi K, Ikeda Y, Haneda E, and Suzuki H (2008) Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. J Neurosci 28:6272–6280.
112. Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, and Lidow MS (2003) Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci USA 100:313–317.
113. Krystal JH, Mathew SJ, D’Souza DC, Garakani A, Gunduz-Bruce H, and Charney DS (2010) Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24:669–693.
114. Kulak A, Steullet P, Cabungcal JH, Werge T, Ingason A, Cuenod M, and Do KQ (2013) Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. Antioxid Redox Signal 18:1428–1443.
115. Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresér KM, Gomes FA, Belmontede-Abreu PS, Berk M, and Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32: 1677–1681.
116. Lee KW, Westin L, Kim J, Chang JC, Oh YS, Amreen B, Gresack J, Flajolet M, Kim D, Aperia A, et al. (2015) Alteration by p11 of mGluR5 localization regulates depression-like behaviors. Mol Psychiatry 20:1546–1556.
117. Leonard B and Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36:764–785.
118. Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, and Daskalakis ZJ (2010) Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 67:458–464.
119. Lock JT, Sinkins WG, and Schilling WP (2011) Effect of protein S-glutathionylation on Ca2+ homeostasis in cultured aortic endothelial cells. Am J Physiol Heart Circ Physiol 300:H493–H506.
120. Lubrich B and van Calker D (1999) Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs? Neuropsychopharmacology 21:519–529.
121. Luo P, Li X, Fei Z, and Poon W (2012) Scaffold protein Homer 1: implications for neurological diseases. Neurochem Int 61:731–738.
122. Luscher B, Shen Q, and Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383–406.
123. Machado-Vieira R, Pivovarova NB, Stanika RI, Yuan P, Wang Y, Zhou R, Zarate CA Jr., Drevets WC, Brantner CA, Baum A, et al. (2011) The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry 69:344–352.
124. Maciag D, Hughes J, O’Dwyer G, Pride Y, Stockmeier CA, Sanacora G, and Rajkowska G (2010) Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry 67:465–470.
125. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11–38.
126. Maes M (2011) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 35:664–675.
127. Malberg JE, Eisch AJ, Nestler EJ, and Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104–9110.
128. Manji HK, Moore GJ, and Chen G (2000) Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61 (Suppl 9):82–96.
129. Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, and Zarate CA (2003) The underlying neurobiology of bipolar disorder. World Psychiatry 2:136–146.
130. Mathews R, Li PP, Young LT, Kish SJ, and Warsh JJ (1997) Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol Psychiatry 41:649–656.
131. McClung CA and Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3–17.
132. Miller AH, Maletic V, and Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732–741.
133. Miller BR and Hen R (2015) The current state of the neurogenic theory of depression and anxiety. Curr Opin Neurobiol 30:51–58.
134. Miller OH, Yang L, Wang CC, Hargroder EA, Zhang Y, Delpire E, and Hall BJ (2014) GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine. eLife 3:e03581.
135. Ming GL and Song H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70:687–702.
136. Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier H, and Ikram MA (2016) 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry 3:628–635.
137. Missiaen L, Taylor CW, and Berridge MJ (1991) Spontaneous calcium release from inositol trisphosphate-sensitive calcium stores. Nature 352:241–244.
138. Money KM, Olah Z, Korade Z, Garbett KA, Shelton RC, and Mirnics K (2016) An altered peripheral IL6 response in major depressive disorder. Neurobiol Dis 89: 46–54.
139. Morris G and Berk M (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med 13:68.
140. Mourao RJ, Mansur G, Malloy-Diniz LF, Castro Costa E, and Diniz BS (2016) Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis. Int J Geriatr Psychiatry 31:905–911.
141. Moy FM, Hoe VC, Hairi NN, Vethakkan SR, and Bulgiba A (2016) Vitamin D deficiency and depression among women from an urban community in a tropical country. Public Health Nutr 18:1–7.
142. Najjar S, Pearlman DM, Alper K, Najjar A, and Devinsky O (2013) Neuroinflammation and psychiatric illness. J Neuroinflammation 10:43.
143. Nassar A and Azab AN (2014) Effects of lithium on inflammation. ACS Chem Neurosci 5:451–458.
144. Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE, Dwyer JM, Fuchikami M, Becker A, Drago F, et al. (2015) Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiol Dis 82:254–261.
145. Newell KA and Matosin N (2014) Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics. BMC Psychiatry 14:23.
146. Niciu MJ, Ionescu DF, Richards EM, and Zarate CA Jr.. (2014) Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna) 121:907–924.
147. Okereke OI and Singh A (2016) The role of vitamin D in the prevention of late-life depression. J Affect Disord 198:1–14.
148. Ostacher MJ, Iosifescu DV, Hay A, Blumenthal SR, Sklar P, and Perlis RH (2014) Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association. Bipolar Disord 16:199–203.
149. Ou X, Crane DE, MacIntosh BJ, Young LT, Arnold P, Ameis S, and Goldstein BI (2015) CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity. Neurosci Biobehav Rev 55:198–210.
150. Pałucha-Poniewiera A, Wierońska JM, Brański P, Burnat G, Chruścicka B, and Pilc A (2013) Is the mGlu5 receptor a possible target for new antidepressant drugs? Pharmacol Rep 65:1506–1511.
151. Park KM, Yule DI, and Bowers WJ (2009) Tumor necrosis factor-a-mediated regulation of the inositol 1,4,5-trisphosphate receptor promoter. J Biol Chem 284: 27557–27566.
152. Patrick RP and Ames BN (2015) Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 29:2207–2222.
153. Paul IA and Skolnick P (2003) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003:250–272.
154. 2+ release channels to hippocampal synaptic plasticity and spatial memory: potential redox modulation. Antioxid Redox Signal 21:892–914.
155. Pereira F, Barbáchano A, Singh PK, Campbell MJ, Muñoz A, and Larriba MJ (2012) Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 11: 1081–1089.
156. Pérez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta López ME, and Tolosa de Talamoni NG (2008) Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway. Digestion 77:22–34.
157. Perrier E, Pompei F, Ruberto G, Vassos E, Collier D, and Frangou S (2011) Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. Eur Psychiatry 26:135–137.
158. Perroy J, Raynaud F, Homburger V, Rousset MC, Telley L, Bockaert J, and Fagni L (2008) Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. J Biol Chem 283:6799–6805.
159. Polak MA, Houghton LA, Reeder AI, Harper MJ, and Conner TS. (2014) Serum 25-hydroxyvitamin D concentrations and depressive symptoms among young adult men and women. Nutrients 6:4720–4730.
160. Pouliquin P and Dulhunty AF (2009) Homer and the ryanodine receptor. Eur Biophys J 39:91–102.
161. Querfurth HW and Selkoe DJ (1994) Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33:4550–4561.
162. Raab-Graham KF, Workman ER, Namjoshi S, and Niere F (2016) Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression. Brain Res 1647:94–104.
163. Rajkowska G, O’Dwyer G, Teleki Z, Stockmeier CA, and Miguel-Hidalgo JJ (2007) GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32:471–482.
164. Ren Z, Pribiag H, Jefferson SJ, Shorey M, Fuchs T, Stellwagen D, and Luscher B (2016) Bidirectional homeostatic regulation of a depression-related brain state by Gamma- Aminobutyric Acidergic deficits and ketamine treatment. Biol Psychiatry 80:457–468.
165. Réus GZ, Titus SE, Abelaira HM, Freitas SM, Tuon T, Quevedo J, and Budni J (2016) Neurochemical correlation between major depressive disorder and neurodegenerative diseases. Life Sci 158:121–129.
166. Rietschel M, Mattheisen M, Frank J, Treutlein J, Degenhardt F, Breuer R, Steffens M, Mier D, Esslinger C, Walter H, et al. (2010) Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 68:578–585.
167. Ryan ZC, Craig TA, Folmes CD, Wang X, Lanza IR, Schaible NS, Salisbury JL, Nair KS, Terzic A, Sieck GC, et al. (2016) 1a,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells. J Biol Chem 291:1514–1528.
168. Saavedra K, Molina-Márquez AM, Saavedra N, Zambrano T, and Salazar LA (2016) Epigenetic modifications of major depressive disorder. Int J Mol Sci 17:1279.
169. Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, and Zarate CA Jr.. (2010) The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry 71:1488–1501.
170. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, and Mason GF (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705–713.
171. Scaini G, Rezin GT, Carvalho AF, Streck EL, Berk M, and Quevedo J (2016) Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications. Neurosci Biobehav Rev 68:694–713.
172. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522.
173. Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y, Szigeti- Buck K, and Ehrlich BE (2006) Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 116: 1668–1674.
174. Serchov T, Clement HW, Schwarz MK, Iasevoli F, Tosh DK, Idzko M, Jacobson KA, de Bartolomeis A, Normann C, Biber K, et al. (2015) Increased signaling via adenosine A1 receptors, sleep deprivation, Imipramine, and Ketamine inhibit depressive-like behavior via induction of Homer1a. Neuron 87:549–562.
175. Serchov T, Heumann R, van Calker D, and Biber K (2016) Signaling pathways regulating Homer1a expression: implications for antidepressant therapy. Biol Chem 397:207–214.
176. Shao L, Cui J, Young LT, and Wang JF (2008) The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience 151: 518–524.
177. Sikoglu EM, Navarro AA, Starr D, Dvir Y, Nwosu BU, Czerniak SM, Rogan RC, Castro MC, Edden RA, Frazier JA, et al. (2015) Vitamin D3 supplemental treatment for mania in youth with Bipolar Spectrum Disorders. J Child Adolesc Psychopharmacol 25:415–424.
178. Silvagno F, Consiglio M, Foglizzo V, Destefanis M, and Pescarmona G (2013) Mitochondrial translocation of vitamin D receptor is mediated by the permeability transition pore in human keratinocyte cell line. PLoS One 8:e54716.
179. Silvagno F, De Vivo E, Attanasio A, Gallo V, Mazzucco G, and Pescarmona G (2010) Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One 5:e8670.
180. Sinha A, Hollingsworth KG, Ball S, and Cheetham T (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98:E509–E513.
181. Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MC, Chaim KT, Gattaz WF, Zarate CA Jr, and Machado-Vieira R (2013) Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology 38:468–475.
182. Steckert AV, Valvassori SS, Moretti M, Dal-Pizzol F, and Quevedo J (2010) Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res 35: 1295–1301.
183. Stewart R and Hirani V (2010) Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 72:608–612.
184. Stokes CS, Grünhage F, Baus C, Volmer DA, Wagenpfeil S, Riemenschneider M, and Lammert F (2016) Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr 35:950–957.
185. Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, and Brandon NJ (2012) Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2:e199.
186. Sutton MA, Taylor AM, Ito HT, Pham A, and Schuman EM (2007) Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis. Neuron 55:648–661.
187. Swardfager W, Rosenblat JD, Benlamri M, and McIntyre RS (2016) Mapping inflammation onto mood: Inflammatory mediators of anhedonia. Neurosci Biobehav Rev 64:148–166.
188. Szumlinski KK, Kalivas PW, and Worley PF (2006) Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol 16:251–257.
189. Tao HW, Li YT, and Zhang LI (2014) Formation of excitation-inhibition balance: inhibition listens and changes its tune. Trends Neurosci 37:528–530.
190. 2+ leak in chronic heart failure. Circ Res 103:1466–1472.
191. Tesli M, Skatun KC, Ousdal OT, Brown AA, Thoresen C, Agartz I, Melle I, Djurovic S, Jensen J, and Andreassen OA (2013) CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS One 8:e56970.
192. Thompson SM, Kallarackal AJ, Kvarta MD, Van Dyke AM, LeGates TA, and Cai X (2015) An excitatory synapse hypothesis of depression. Trends Neurosci 38: 279–294.
193. Tsankova N, Renthal W, Kumar A, and Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355–367.
194. Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ, and Worley PF (1998) Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21:717–726.
195. Turek FW (2005) Insomnia and depression: if it looks and walks like a duck…. Sleep 28:1362–1363.
196. Turrigiano GG (2008) The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135:422–435.
197. Uemura T, Green M, Corson TW, Perova T, Li PP, and Warsh JJ (2011) Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder. Bipolar Disord 13:41–51.
198. Uemura T, Green M, and Warsh JJ (2015) CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis. World J Biol Psychiatry 17: 525–534.
199. Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, and Engelborghs S (2014) Depression in mild cognitive impairment is associated with progression to Alzheimer’s disease: a longitudinal study. J Alzheimers Dis 42:1239–1250.
200. von Känel R, Fardad N, Steurer N, Horak N, Hindermann E, Fischer F, and Gessler K (2015) Vitamin D deficiency and depressive symptomatology in psychiatric patients hospitalized with a current depressive episode: A factor analytic study. PLoS One 10:e0138550.
201. Wang JF, Shao L, Sun X, and Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 11:523–529.
202. Warsh JJ, Andreopoulos S, and Li PP (2004) Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clin Neurosci Res 4:201–213.
203. Wasserman RH (2004) Vitamin D and the dual processes of intestinal calcium absorption. J Nutr 134: 3137–3139.
204. Wei R and Christakos S (2015) Mechanisms underlying the regulation of innate and adaptive immunity by Vitamin D. Nutrients 7:8251–8260.
205. Wohleb ES, Franklin T, Iwata M, and Duman RS (2016) Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 17:497–511.
206. Wohleb ES, Gerhard D, Thomas A, and Duman RS (2017) Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine. Curr Neuropharmacol 15:11–20.
207. Wyskiel DR and Andrade R (2016) Serotonin excites hippocampal CA1 GABAergic interneurons at the stratum radiatum-stratum lacunosum moleculare border. Hippocampus 26:1107–1114.
208. Xia L, Zhang D, Wang C, Wei F, and Hu Y (2012) PC-PLC is involved in osteoclastogenesis induced by TNF-a through upregulating IP3R1 expression. FEBS Lett 586:3341–3348.
209. Yuan JP, Kiselyov K, Shin DM, Chen J, Shcheynikov N, Kang SH, Dehoff MH, Schwarz MK, Seeburg PH, Muallem S, et al. (2003) Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. Cell 114:777–789.
210. Zhang C, Wu Z, Zhao G, Wang F, and Fang Y (2016b) Identification of IL6 as a susceptibility gene for major depressive disorder. Sci Rep 6:31264.
211. Zhang X, Tang Y, Maletic-Savatic M, Sheng J, Zhang X, Zhu Y, Zhang T, Wang J, Tong S, Wang J, et al. (2016a) Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study. J Affect Disord 201:153–161.
212. Zhang X, Zhang C, Wu Z, Wang Z, Peng D, Chen J, Hong W, Yuan C, Li Z, Yu S, et al. (2013) Association of genetic variation in CACNA1C with bipolar disorder in Han Chinese. J Affect Disord 150:261–265.
213. Zorov DB, Juhaszova M, and Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94:909–950.